doi: 10.1016/j.tibtech.2004.03.006.
A revival of bispecific antibodies
Affiliations
- PMID: 15109810
- DOI: 10.1016/j.tibtech.2004.03.006
Item in Clipboard
A revival of bispecific antibodies
Trends Biotechnol.
2004 May.
No abstract available
Similar articles
-
Expression and purification of monospecific and bispecific recombinant antibody fragments derived from antibodies that block the CD80/CD86-CD28 costimulatory pathway.Protein Expr Purif. 2001 Jun;22(1):11-24. doi: 10.1006/prep.2001.1417. Protein Expr Purif. 2001. PMID: 11388794
-
Recombinant bispecific antibodies for cellular cancer immunotherapy.Curr Opin Mol Ther. 2007 Aug;9(4):319-26. Curr Opin Mol Ther. 2007. PMID: 17694444 Review.
-
Therapeutic assessment of SEED: a new engineered antibody platform designed to generate mono- and bispecific antibodies.Protein Eng Des Sel. 2011 May;24(5):447-54. doi: 10.1093/protein/gzq123. Protein Eng Des Sel. 2011. PMID: 21498564
-
[Bispecific antibodies: what future?].Med Sci (Paris). 2009 Dec;25(12):1155-8. doi: 10.1051/medsci/200925121155. Med Sci (Paris). 2009. PMID: 20035697 Review. French.
-
Immunology. Two-in-one designer antibodies.Science. 2009 Mar 20;323(5921):1567-8. doi: 10.1126/science.1172253. Science. 2009. PMID: 19299606 No abstract available.
Cited by
-
Application of quantitative pharmacology in development of therapeutic monoclonal antibodies.AAPS J. 2010 Dec;12(4):592-601. doi: 10.1208/s12248-010-9220-2. Epub 2010 Jul 24. AAPS J. 2010. PMID: 20652780 Free PMC article. Review.
-
Antagonistic VEGF variants engineered to simultaneously bind to and inhibit VEGFR2 and alphavbeta3 integrin.Proc Natl Acad Sci U S A. 2011 Aug 23;108(34):14067-72. doi: 10.1073/pnas.1016635108. Epub 2011 Aug 8. Proc Natl Acad Sci U S A. 2011. PMID: 21825147 Free PMC article.
-
Asymmetrical Fc engineering greatly enhances antibody-dependent cellular cytotoxicity (ADCC) effector function and stability of the modified antibodies.J Biol Chem. 2014 Feb 7;289(6):3571-90. doi: 10.1074/jbc.M113.513366. Epub 2013 Dec 5. J Biol Chem. 2014. PMID: 24311787 Free PMC article.
-
Understanding the structure-property relationship of bispecific monoclonal antibodies with Fc site-specific substitutions.MAbs. 2023 Jan-Dec;15(1):2228006. doi: 10.1080/19420862.2023.2228006. MAbs. 2023. PMID: 37357447 Free PMC article.
-
Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies.BioDrugs. 2018 Oct;32(5):441-464. doi: 10.1007/s40259-018-0299-9. BioDrugs. 2018. PMID: 30132211 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
